Corbus Pharmaceuticals Holdings Inc at RBC Capital Markets Global Healthcare Conference Transcript
(audio in progress) Senior biotech analyst here at RBC Capital Markets. Good afternoon. Really pleased to have our next presenting company at Corbus, represented by their CEO, Yuval Cohen. Yuval, thanks for being here again.
Thank you, Brian. Appreciate it.
Questions & Answers
Maybe just starting with, the most, I guess, timely, data event that we're going to be looking towards, ASCO. Just a couple of weeks away. Can you maybe tee up for us what we should be expecting to see now from the more mature monotherapy data for seven zero one in terms of durability, PFS, some of the biomarker impacts, things like HPV positive or negative or some of the other subgroups that we might be looking at? Any sense as to the degree of follow-up data that we might see from your partner as well at the upcoming meeting and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
